Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Cannovum AG, DE000A2LQU21

Cannovum AG, DE000A2LQU21

08.09.2021 - 13:47:35

Cannovum AG expands Supervisory Board and Medical Advisory Board

Cannovum AG is the first German listed medical cannabis company. The shares are traded on the D?sseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Through its subsidiary Cannovum Health eG, Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin. The company focuses on the import of high-quality cannabinoid products, medical-scientific education and all-encompassing distribution for simplified and facilitated access to cannabis-based therapies.

For more information, visit www.cannovum.com

08.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Cannovum AG Rheinsberger Str. 76/77 10115 Berlin

Germany Phone: +49 (0)30 3982 16360 E-mail: ir@cannovum.com Internet: www.cannovum.com ISIN: DE000A2LQU21 WKN: A2LQU2 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich EQS News ID: 1232051 ? End of News DGAP News Service

1232051??08.09.2021?

@ dgap.de